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0022-2836/$ - see front matter © 2008 EDeoxycytidine kinase (dCK) is an essential nucleoside kinase critical for the
production of nucleotide precursors for DNA synthesis. This enzyme
catalyzes the initial conversion of the nucleosides deoxyadenosine (dA),
deoxyguanosine (dG), and deoxycytidine (dC) into their monophosphate
forms, with subsequent phosphorylation to the triphosphate forms
performed by additional enzymes. Several nucleoside analog prodrugs
are dependent on dCK for their pharmacological activation, and even
nucleosides of the non-physiological L-chirality are phosphorylated by
dCK. In addition to accepting dC and purine nucleosides (and their analogs)
as phosphoryl acceptors, dCK can utilize either ATP or UTP as phosphoryl
donors. To unravel the structural basis for substrate promiscuity of dCK at
both the nucleoside acceptor and nucleotide donor sites, we solved the
crystal structures of the enzyme as ternary complexes with the two
enantiomeric forms of dA (D-dA, or L-dA), with either UDP or ADP bound
to the donor site. The complexes with UDP revealed an open state of dCK in
which the nucleoside, either D-dA or L-dA, is surprisingly bound in a
manner not consistent with catalysis. In contrast, the complexes with ADP,
with either D-dA or L-dA, adopted a closed and catalytically competent
conformation. The differential states adopted by dCK in response to the
nature of the nucleotide were also detected by tryptophan fluorescence
experiments. Thus, we are in the unique position to observe differential
effects at the acceptor site due to the nature of the nucleotide at the donor
site, allowing us to rationalize the different kinetic properties observed with
UTP to those with ATP.© 2008 Elsevier Ltd. All rights reserved.Keywords: deoxycytidine kinase; phosphoryl transfer; L-nucleosides;
deoxyadenosine; crystal structureEdited by K. MorikawaIntroduction
Human deoxycytidine kinase (dCK) is a salvage-
pathway enzyme responsible for the conversion of
deoxycytidine (dC), deoxyadenosine (dA) and
deoxyguanosine (dG) into their monophosphate
forms. The enzyme is also responsible for the
activation via phosphorylation of important
nucleoside analogs (NAs) used for the treatment
of different types of cancers (e.g., cytarabine,ess: Lavie@uic.edu.
ytidine kinase; NA,
K variant in which
, and C146) were
e.
lsevier Ltd. All rights reservegemcitabine, cladribine and fludarabine) and viral
infections (e.g., lamivudine and emtracitabine).
Interestingly, both ATP and UTP can act as
phosphoryl donors, and it has been suggested
that UTP is the in vivo relevant donor.1 In addition,
dCK has the ability to phosphorylate NAs of the
non-physiological L-chirality.2
The low substrate selectivity of dCK at both the
donor and acceptor sites, allowing molecules that
differ in size, shape, chirality, and hydrogen
bonding pattern to be substrates, suggests that
the enzyme can adjust its conformation to preserve
its catalytic power. However, before this work our
understanding of how dCK maintains its enzy-
matic activity with such diverse substrates has
been limited. For example, previous structures of
dCK contained pyrimidine nucleosides at the
acceptor site,3–5 except for the sole structure ofd.
608 Human dCK in Complex With L/D-d/A and UDP/ADPdCK in complex with the purine clofarabine, a
structure solved at medium resolution and that
exhibits very high B-factors.6 Additionally, the only
structure of dCK with a uridine nucleotide at the
donor site was solved at low resolution and
employed a dCK variant lacking its insert region.7
Lastly, the recently reported structural analyses of
phosphorylation of L-nucleosides by dCK were
limited to pyrimidine nucleosides.4,5
We set out to address the following questions: (1)
what structural adjustments take place upon binding
of the physiological purine substrate dA, in compar-
ison to the pyrimidine dC? (2) How is the nature of
the nucleotide at the donor site sensed by the
enzyme? (3) How do the acceptor and donor binding
sites communicate, as suggested by the fact that the
donor identity affects the kinetic parameters of the
nucleoside, and vice versa? (4) What are the structural
ramifications of binding to the non-physiological L-
form of dA? To address these questions, we solved
the three-dimensional structures of dCK in complex
with the purine nucleosidedA (in the formof either D-
dA or L-dA) at the nucleoside-binding site, and either
ADP or UDP at the phosphate donor site. Apart from
supplying the first view of dCK bound to one of its
physiological purine substrates, a surprising result of
this work was the detection of an open dCK
conformation in the presence of uridine nucleotides.
This state, corroborated by tryptophan fluorescence
studies, rationalizes the different kinetic behavior
observed for dCK when UTP is exchanged for ATP.
This work increases our understanding of the
structural basis for the substrate promiscuity of dCK.Results and Discussion
Structural work on human dCK has been severely
hampered by the difficulty of obtaining diffraction-
quality crystals. For example, whereas wild type
(WT) dCK forms good crystals as a ternary complex
with ADP at the donor site and various pyrimidine
nucleosides at the acceptor site, we could not obtain
crystals when UDP was used instead of ADP. This
was an early indication that dCK adjusts its
conformation according to the nature of the nucleo-
tides present. A major effort was initiated to identify
a variant of the enzyme that would form good
crystals with a wider set of substrates. We specu-
lated that one possible hindrance to crystallization
was the presence of surface cysteine residues.
Therefore, a variant of dCK that has four of its six
cysteine residues mutated to serine was generated.
Extensive structural and kinetic analysis of this so-
called C4S-dCK variant revealed that it is a good
analog of WT-dCK.4 For example, several structures
previously solved withWT-dCKwere repeated with
the C4S variant. Comparison of these structures
revealed an identical overall fold, and an identical
nucleoside and nucleotide conformation.4,5 Impor-
tantly, unlikeWT-dCK, the C4S-dCK variant exhibits
an improved propensity for crystallization. Three of
the structures of dCK reported here employed theC4S-variant. One, the D-dA/ADP complex, crystal-
lized when an additional surface residue, Glu247,
was mutated to alanine (see Materials and Meth-
ods). Kinetic and fluorescence studies were done on
both the C4S and the WT-dCK proteins.
Here, we present four ternary complexes of dCK
that contain either the D- or the L-form of dA at the
nucleoside acceptor site, plus either ADP or UDP at
the phosphoryl donor site. For clarity, we specifi-
cally designate the chirality of the nucleosides
discussed (e.g. D-dA or L-dA). Data collection and
refinement statistics for the D-dA/ADP (to 2.3 Å
resolution), L-dA/ADP (2.2 Å), D-dA/UDP (1.77 Å),
and L-dA/UDP (1.77 Å) complexes are presented in
Table 1.
Side chain adjustments of active site residues
allows dCK to bind either purine or pyrimidine
nucleosides: comparison of the D-dA/ADP to the
D-dC/ADP complexes
One of the goals of this work was to elucidate the
structural properties of dCK that allow this nucleo-
side kinase to phosphorylate both purine and
pyrimidine substrates. Comparison of ternary D-
dA/ADP (i.e. a purine at the acceptor site) and D-
dC/ADP (i.e. a pyrimidine at the acceptor site; PDB
ID 1P60) complex structures shows that the overall
fold of the enzyme is very similar (Fig. 1a). There are
no significant differences in the positioning of main-
chain atoms (rmsd between the D-dA/ADP structure
and the D-dC/ADP structure is 0.29 Å on 239 Cα
atoms). An additional correspondence lies in the
insert region. In the previous structure of dCK in
complex with D-dC/ADP, we could model the insert
region in only one of the twomolecules that build the
asymmetric unit.3 In the D-dA/ADP complex, which
also contains a dimer in the asymmetric unit, we
observe excellent electron density for the insert
region for one of the monomers, and in a conforma-
tion identical with that in the D-dC/ADP complex.
While no gross conformational difference exists
between the pyrimidine (D-dC) and the purine (D-
dA) bound states, several active site residues do
slightly adjust their position according to the shape,
size, and hydrogen bonding capabilities of the
substrate. For example, Asp133 is closer to the
amino group of the adenine moiety compared to
the amino group of the cytosine ring (2.5 Å versus
2.9 Å) and concomitantly Arg104 readjusts its
position to make a tighter interaction with Asp133
(Fig. 1b). Also, in the D-dA structure, the side chain of
Gln97 rotates slightly, keeping the oxygen of the
amide group in the same positionwhile adjusting the
position of the NH2-group slightly in order to
accommodate atom N1 of dA (see Supplementary
Data Fig. S1). The larger purine ring in D-dA results
in the displacement of a water molecule that
otherwise bridges the carbonyl group of D-dC and
Gln97. On the other hand, the water molecule
bridging D-dC and Tyr86 is retained in the D-dA
structure. For this, D-dA uses its ring N3 instead of
the carbonyl group used by D-dC. This water-
Table 1. Data collection and refinement statistics
dCK mutant C4S+E247A C4S C4S C4S
Complex D-dA/ADP L-dA/ADP D-dA/UDP L-dA/UDP
PDB codes 2ZI3 2ZI4 2ZI6 2ZI5
Crystal growth
temperauture (°C)
22 22 12 12









Wavelength (Å) 1.0 1.5418 1.5418 1.5418
Temperature (K) 100 100 100 100
Resolutiona (Å) 2.3 (2.3–2.4) 1.76 (1.76–1.87) 1.77 (1.77–1.87) 1.77 (1.77–1.87)
No. reflections
Observed 112,092 274,380 528,419 76,8651
Unique 23,174 30,274 109,802 110,589
Completeness (%) 93.0 (81.8) 99.5 (97.6) 98.6 (93.0) 99.0 (95.4)
Rsym (%) 13.2 (54.5) 11.1 (34.6) 7.1 (41.4) 6.7 (52.2)
I/σ(I) 8.4 (2.6) 13.9 (6.0) 13.4 (3.0) 16.6 (3.1)
Space group C2221 P43212 C2221 C2221
Unit cell
a (Å) 52.44 79.73 138.25 138.36
b (Å) 133.29 79.73 138.51 138.65
c (Å) 156.73 93.53 118.67 119.01
Refinement program REFMAC5 REFMAC5 SHELXL SHELXL
Twinning fraction – – 0.48265 0.50115
Refinement statistics
Rcryst (%) 20.8 17.9 20.8 21.9
Rfree (%) 30.6 25.7 28.3 29.3
Resolution range (Å) 30–2.3 30–2.2 30–1.77 30–1.77
Molecules per a.u. 2 1 4 4
Number of atoms




D-dA/L-dA 18× 2 18×1 18×4 18×4
ADP/UDP 27×2 27×1 25×4 25×4
Water 104 86 165 211
r.m.s. deviation from ideal
Bond lengths (Å) 0.015 0.014 0.007 0.006
Bond angles (deg) 1.738 1.572 – –
Angle distance (Å) – – 0.027 0.023
Average B-factors (Å2)/chain
Protein 39, 41 33 29, 27, 30, 27 35, 32, 35, 33
D-dA/L-dA 32, 33 20 23, 18, 30, 20 33, 35, 35, 34
ADP/UDP 27, 29 22 24, 27; 26; 23 31, 28, 36, 32
Water molecules 39 36 27 34
Ramachandran plot regions
Most favored (%) 91.5 93.2 87.2 86.1
Additionally allowed (%) 7.3 6.3 11.7 12.9
Generously allowed (%) 0.9 0.5 0.9 0.9
Disallowed (%) 0.2 0.0 0.3 0.1
a Last shell in parentheses.
609Human dCK in Complex With L/D-d/A and UDP/ADPmediated nucleoside–protein interaction is impor-
tant for positioning of the side chain of Tyr86. The
position of this residue, which also interacts with the
3′-OH group of the nucleoside, seems to be critical
for the ability of dCK to adopt a closed and active
conformation (see below).
Interestingly, when it comes to the binding and
orientation of the nucleosides, the amino groups of
the bases (N4 in dC, N6 in dA) are in nearly identical
positions (arrow, Fig. 1b), and so are the respective
3′- and the 5′-OH groups of the sugar moieties. This
allows the protein to maintain a similar hydrogen
bonding pattern irrespective to the base nature of the
nucleoside, and to correctly orient and activate the
5′-OH group for nucleophilic attack on the phos-
phoryl donor. In summary, in order to accommodate
the larger purine substrates, dCK adjusts the positionof active site residues so that homologous interac-
tions as seen with pyrimidines substrates can be
made.
The nature of the nucleotide at the phosphoryl
donor site determines the conformation of dCK:
comparison of the D-dA/ADP to D-dA/UDP
structures
In contrast to a preserved enzyme conformation
between the D-dC and the D-dA complexes, both
with ADP at the phosphoryl donor site, comparison
of the D-dA/ADP to the D-dA/UDP structures (i.e.,
the same purine at the nucleoside site, but a different
diphosphate at the donor site) shows that binding of
different nucleotides results in differences in the
overall-fold of the protein, leading to an rmsd value
Fig. 1. Binding of the purine dA relative to the pyrimidine dC requires only a slight adjustment of active site residues.
(a) A stereoview of the overlay of the D-dA/ADP complex (blue) on the D-dC/ADP complex (yellow; PDB ID 1P60). Note
the nearly perfect overlay of the protein, and of the nucleosides/nucleotides. (b) The larger adenine ring of dA induces
movement in several active site residues relative to their position with dC. This permits the maintenance of enzyme–
nucleoside interactions. Importantly, the side chain of Glu53 maintains its interaction with the D-dA 5′-OH group. The
short distances between Asp133 to Arg104, and Glu197 to the 3′-OH group were verified by inspection of electron density
maps. Met85 in the D-dC structure exhibited two conformations; both are shown. All structure figures were prepared
using MOLSCRIPT19 or Bobscript,20 and rendered with Raster3D.21
610 Human dCK in Complex With L/D-d/A and UDP/ADPof 0.89 Å on 206 Cα atoms. The main differences in
conformations that the enzyme assumes in the two
complexes are predominantly confined to three
sections (labeled A, B and C in Fig. 2a) that, while
discontinuous in their sequence, together build a
continuous surface.
We propose that the three distinct areas A, B and C
communicate between each other upon binding of
either ADP or UDP, and that this ultimately affects
the conformation of the nucleoside. To illustrate how
this communication may take place, we will start by
analyzing the structural differences that occur in
region A, the region involved in the binding of the
base moiety of the nucleotides. We observe that thisregion senses the difference between ADP and UDP,
and accordingly adjusts the conformation of the
loop that directly interacts with the base moiety of
the donor (arrow 1, base-sensing loop in Fig. 2a). A
similar conformational change for this loop occur-
ring upon binding of UDP, described by Godsey et
al.,7 was observed in the structural examination of a
dCK variant lacking the insert region (the insert
region is a component of region C). The fact that we
also observe this same main-chain reorganization in
response to the nature of the phosphoryl donor,
using a construct of full-length dCK, verifies this
conformational response to the nature of the
phosphoryl donor. The change in conformation of
Fig. 2. Binding of UDP instead of ADP results in conformational changes limited to three regions. (a) Overlay of the
D-dA/ADP and the D-dA/UDP structures. Regions that overlay well are colored gray. The three regions that differ in
conformation between the two complexes are region A (ADP complex in dark purple, UDP complex in light purple),
region B (ADP complex in red, UDP complex in yellow), and region C (ADP complex in dark green, UDP complex in
light green). Arrows point at the important motifs that belong to each region: Insert, LID, and Base-sensing loop. The
nucleoside/nucleotide is shown in dark blue for the ADP complex, and in light blue for the UDP complex. The coloring
scheme in panel a is used in all panels. (b) A stereoview of the base-sensing loop. Note the complete reorganization of
this loop according to the nature of the diphosphate. (c) Close-up of the base (adenine or uracil) – enzyme interaction.
The amino group of ADP overlays on the carbonyl group of UDP (marked with an asterisk (*)). The different hydrogen
bonding properties of these moieties induce the adjustment in enzyme conformation. The carbonyl group of Glu240
(circled in green), which interacts with the amino group in the ADP structure, is forced to increase its distance to the
UDP carbonyl group. (d) A stereoview of the region B – region C interface. In the open UDP structure, Glu196 cannot
maintain its interaction with Asn80 as seen in the ADP complex. Note also the different conformations of Trp58 and
Tyr86 in region C. (e) Close-up of the stacking interaction between the guanidinium group of Arg188 and the base
moiety of ADP or UDP. Positioning of Arg188 may determine the conformation of the enzyme, since this residue acts to
line regions A and B.
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612 Human dCK in Complex With L/D-d/A and UDP/ADPthe loop that directly interacts with the base (for
details see Fig. 2b) extends to the whole region that
we identify as region A (residues 240–254; the ADP
complex in dark purple and the UDP complex in
light purple).
What is the structural feature that discriminates a
uracil base from an adenine moiety? With ADP, the
amino group (N6) interacts (3.2 Å) with the main-
chain carbonyl group of Glu240, while nitrogen N1
accepts an H-bond from the main-chain -NH- of
Phe242 (Fig. 2c). Upon binding of UDP, the
carbonyl group in position 4 of the uracil base
binds in the same position as the amino group (N6)
of the adenine ring (labeled with an asterisk (*) in
Fig. 2c). If dCK would maintain its ADP-bound
conformation, an unfavorable interaction between
the uracil carbonyl group and the Glu240 carbonyl
group would take place (the position of the
carbonyl group of Glu240 in the ADP and UDP
structures is marked by green circles in Fig. 2c).
This is possibly the driving force for reorganization
of the base-sensing loop. The carbonyl group of
Glu240 increases its distance to the uracil base by
reorganizing Phe242 and attracting the side chain
of Asp241 closer to the uracil ring. This movement
allows for the formation of a stabilizing hydrogen
bond between N3 of the uracil base and the
carboxylic group of Asp241 (Fig. 2c). To recapitu-
late, the base-sensing loop adopts a main-chain
conformation that varies according to the nature of
the nucleotides, resulting in different enzyme–
nucleotide base interactions taking place.
A second area that changes conformation due to
the presence of UDP versus ADP is region B
(residues 179–207 in red and yellow, Fig. 2d). This
region encompasses the LID motif (arrow 2 in Fig.
2a), an important motif in nucleoside kinases that
contains several arginine residues that take part in
nucleotide donor binding and in transition state
stabilization. How does region B sense the nature of
the phosphoryl donor (ADP versus UDP)? Inspec-
tion of the structures does not provide a clear
communication pathway connecting the base-sen-
sing loop in region A to region B. One possible
information flow involves Arg188 that acts to
directly connect the LID motif with the base-sensing
loop (Fig. 2e). However, due to the relatively small
change in position for the atoms involved in this
interaction (about 0.4 Å), this model for commu-
nication between regions A and B must be validated
by further experiments. An alternative explanation
for the difference in conformation of region B
involves the direct sensing of the nature of the
donor by the LID arginine Arg188. The guanidinium
group of Arg188 makes a π–π interaction with either
the adenine or uracil base of the nucleotides. Since
the respective base moieties are somewhat displaced
relative to each other, the position of the side chain
of Arg188 adjusts accordingly, and this adjustment
propagates to the entire region B (Fig. 2e).
The third region that varies significantly in
conformation between the ADP and UDP structures
is region C (arrow 3 in Fig. 2a). The insert sequenceis a component of region C. The insert sequence
extends in dCK from residue 63 to residue 77. The
role of the insert in dCK is still not clear but our
studies of a dCK variant lacking this insert7 have
shown a change in the selectivity of the enzyme
between pyrimidine and purine substrates. In all the
ADP-containing dCK structures solved so far where
the insert was traceable (attributed to stabilization of
the insert through crystal packing), this region
adopts the same conformation. In the UDP-contain-
ing structure presented here there is no clear
electron density for residues 59–79. However, it is
evident from those modeled residues flanking the
insert region that in the presence of UDP the insert
region adopts an entirely different conformation
from the one modeled in the presence of ADP. It is
noteworthy that the residues that move the most
between the ADP and the UDP structures are
located just before and just after the insert region:
Trp58, Asn80, and Tyr86 (Fig. 2d).
To reiterate, the presence of UDP or ADP, first
sensed by region A, influences the conformation of
region B to become more open, which in turn
determines the conformation of region C. Residues
from regions B and C interact directly with the
nucleoside. In the ADP complex, the closed con-
formation of the LID (region B) allows a direct
interaction with region C (i.e., Glu196 with Asn80,
Fig. 2d). In contrast, due to the open LID conforma-
tion in the UDP complex, this interaction connecting
region B to region C is not possible. In fact, Asn80, a
residue flanking the insert region, adopts a very
different conformation between the two complexes
(Fig. 2d). Importantly, in the closed LID conforma-
tion (i.e., with ADP), a direct interaction (2.3 Å)
between the LID residue Glu197 and the 3′-OH
group of D-dA takes place, thereby stabilizing the
closed state. Such an interaction is not possible in the
presence of UDP (the distance between Glu197 and
the 3′-OH increases to 5.2 Å; Fig. 3a). To summarize
this section, dCK has the ability to sense the nature
of the nucleotide at the donor site, and when bound
to UDP instead of ADP, the enzyme adopts a more
open conformation in regions A, B, and C.
The identity of the nucleotide bound at the donor
site affects the conformation of the nucleoside
at the acceptor site
In addition to the changes in dCK conformation in
regions A, B and C discussed above, superposition
of the structures solved in the presence of ADP
versus UDP reveals a striking difference in the
conformation of the nucleoside D-dA. In the ADP
complex, D-dA binds in the anti conformation. This
allows residues Tyr86 and Glu197 to hydrogen bond
with the 3′-OH group of the nucleoside (Fig. 3a). We
designate this conformation as active because in this
conformation the 5′-OH group of D-dA is within
hydrogen bonding distance to Glu53 (2.4 Å, Fig. 3a).
This closed conformation allows Glu53 to act as a
base that activates the 5′-OH for attack on the γ-
phosphate group of the phosphoryl donor. This is
613Human dCK in Complex With L/D-d/A and UDP/ADPthe typical conformation adopted by all the pyr-
imidine+ADP structures that we have solved so
far.3–5Fig. 3. The base moiety of D- and L-dA occupy the same reg
site, whereas the position of the sugar component of the nucleo
nucleoside and active site residues of the D-dA/ADP (dark blu
interactions are marked by broken lines in the corresponding
absent in the UDP complex are detailed by thick light blue arro
at the donor site, but in the syn conformation when UDP
conformation, the base moiety occupies the same space and the
In contrast, the sugar moiety of D-dA in the presence of UDP
Glu197 (via the 3′-OH) are lost. Therefore, we designate this co
rotation relative to the view in panel a. In this view, the large ch
in these and subsequent figures as a common reference point.
the L-dA/ADP (dark pink) and D-dA/UDP (light pink) stru
overlays well, despite the different relative orientation (both
significantly different position, so that the important interacti
with UDP. (d) A ∼45° rotation relative to the view in (c).In contrast, in the D-dA complex with UDP, the
nucleoside binds in the unexpected syn conforma-
tion. The base moiety of the D-dA bound in synion regardless of the nature of the nucleotide at the donor
side is determined by the nucleotide. (a) An overlay of the
e) and D-dA/UDP (light blue) structures. Hydrogen bond
colors, with the distance given in Å. Interactions that are
ws. The D-dA binds in the anti conformation when ADP is
is at the donor site. Despite the different nucleoside
interactions to the enzyme are recapitulated in both cases.
is such that the interactions to Glu53 (via the 5′-OH) and
nformation as inactive. See the text for details. (b) A ∼45°
ange in conformation of Trp58 is apparent. Asp133 is used
(c) An overlay of the nucleoside and active site residues of
ctures. Here too, the adenine portion of the nucleoside
are in the anti conformation). The sugars of L-dA are in a
ons to Glu53 and Glu197 cannot be made in the complex
614 Human dCK in Complex With L/D-d/A and UDP/ADP(UDP complex) is turned 180° relative to the base in
the ADP complex that is in anti. Nevertheless, the
adenine ring preserves the same hydrogen-bonding
pattern with the enzyme regardless of being in syn
or anti. The adenine amino group is at the same
position in both the syn and anti conformations,
preserving its interaction with Asp133. On the other
hand, the interaction with the side chain of Gln97 is
via N1 when the base is in anti (ADP complex), and
is replaced by N7 when the base is in syn (UDP
complex) (Fig. 3a). While the adenine moieties of
D-dA occupy the same binding site regardless of
their conformation (syn or anti), the sugar moieties of
the nucleosides occupy entirely different positions.
The 5′-OH group of syn D-dA is 4.4 Å away from
Glu53 while it is 2.4 Å away in the anti D-dA. Such a
large separation between Glu53 and the 5′-OH
suggests that the state we have trapped within the
D-dA/UDP structurewould be catalytically inactive.
How can we rationalize this observation where
the enzyme conformation is not compatible with
catalysis? In fact, kinetic experiments show that dCK
is active with UTP as phosphoryl donor (Table 2).
Thus, we interpret the observed enzyme conforma-
tion as an intermediate state during the catalytic
cycle. The fact that we were able to trap such a state
for the UDP complex, but not for the ADP complex,
may be related to the different mechanism of action
of dCK when it uses UTP versusATP.8,9 It is not clear
if the enzyme also goes through such a state in the
presence of ATP, but fluorescence experiments are
consistent with dCK adopting a different conforma-
tion upon UTP binding versus that adopted upon
ATP binding (see below). Moreover, the different
kinetic parameters measured in the presence of ATP
or UTP as phosphoryl donors are consistent with the
fact that we observed different states for the
complexes with ADP to those with UDP.
In the D-dA/UDP complex, the adoption of the
syn conformation by D-dA and its rotation by 180°
compared to its conformation in the ADP complex is
accompanied by adjustment in the position of
neighboring residues. Most notably are changes
in Val55, Trp58, Tyr86, and Glu197 (Fig. 3). In the
D-dA/ADP complex, Trp58 and the adenine ring
are perpendicular to each other, while in the D-dA/
UDP structure, Trp58 rotates away from the
nucleoside and is at ∼45° to the base of dA (Fig.Table 2. Kinetic analysis of C4S-dCK and WT-dCK using
ATP or UTP as donors and D-dA or L-dA as acceptors
Substrates Enzyme kcat Km (D/L-dA) kcat/Km (×10
−3)
D-dA+ATP WT 2.13 115 18.5
C4S 1.85 311 5.9
L-dA+ATP WT 0.92 110 8.4
C4S 0.84 190 4.4
D-dA+UTP WT 0.37 8 46
C4S 0.24 44 5.5
L-dA+UTP WT 0.24 b5 N48.0
C4S 0.31 16 19.4
Values shown are the averages of at least two experiments. kcat
are in s−1, Km are in μM, and kcat/Km are in μM−1 s−1.3b). Val55 moves accordingly, always facing Trp58.
Despite these considerable conformational changes,
the catalytically important Glu53 maintains the
same position, being anchored by the preceding
and following proline residues (Pro52 and Pro54).
This change in conformation of the nucleoside and
its adjacent active site residues, depending on the
nature of the donor, ADP versus UDP, is recapitu-
lated in the complexes where L-dA is present
instead of D-dA (see below and Fig. 3c and d).
The L- versus the D-enantiomer of dA
The above discussion compared complexes of
dCK that differ either in the nature of the nucleoside
acceptor (D-dC versus D-dA, both with ADP) or in
the nature of the nucleotide donor (ADP versusUDP,
both with D-dA). An additional point we set out to
delineate is the structural properties that allow dCK
to phosphorylate both physiological (D-form) and
non-physiological (L-form) nucleosides. The enzyme
dCK is rather unique in not being enantioselective.
Addressing this question has medicinal implications
as several antiviral nucleoside analogs possess the
L-chirality, and are dependent on dCK for their
pharmacological activity.
In our previous work we addressed this question
in the case of pyrimidine substrates with the L-
chirality, e.g. L-dC and lamivudine.4,5 To reveal if the
same conformational adjustments as seen for L-
pyrimidine substrates take place with purines, we
solved the structure of dCK in complex with L-dA,
with either ADP or UDP at the donor site.
Comparison of the D-dA/ADP to L-dA/ADP
structure
In the ADP complex, L-dA binds in the active site
of dCK in a very similar way compared to L-dC
(Fig. 4), the only main difference being the position-
ing of residue Gln97, which moves further away
from the active site in order to make space for the
larger adenine ring. Additionally, the water mole-
cule formerly bridging between the carbonyl group
of the cytosine base and Gln97 gets displaced in the
L-dA structures. However, the water molecule
bridging the adenine ring and Tyr86 is retained.
This scenario is very similar to that discussed
previously for the D-dC and D-dA couple (Fig. 1b).
Comparison of the protein conformation between
the D-dA and L-dA structures solved in the presence
of ADP are somewhat complicated by the fact that
the enzyme crystallized in different space groups.
The D-dA/ADP complex was solved in an orthor-
hombic space groupwhile L-dA/ADP in a tetragonal
space group. The main difference between the two
space groups is that in the tetragonal space group,
due to crystal packing, Arg192 points away from the
ADP molecule. This is a common feature that has
been observed so far for all the dCK structures
solved in the tetragonal space group (PDB codes
1P5Z, 1P61, and 1P62). We note this because some
of the differences between D-dA/ADP and L-dA/
Fig. 4. Binding mode of L-dA resembles that of L-dC. The overall fold of the enzyme is maintained (a closed
conformation), and active site residues need only to adjust slightly to accommodate the large purine ring. Importantly, the
water molecule bridging the base of the nucleoside (either via the carbonyl of L-dC, or nitrogen N3 of L-dA) and Tyr86 is
retained, supporting the enzyme adopting the closed and active conformation. Met85 in the L-dC structure exhibited two
conformations; both are shown.
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group. Thus, a component of the rmsd (0.64 Å on
226 atoms) between the D-dA/ADP and the L-dA/
ADP can be attributed to crystal packing, and not
to the difference in chirality of the nucleoside
acceptor. In other words, when taking into con-
sideration differences due to crystal packing, the
conformation of dCK between the D-dA/ADP and
the L-dA/ADP structures is very similar. That is,
the enzyme adopts the closed conformation for
regions A, B, and C in both complexes.
Concerning the conformation of the nucleoside
dA, the adenine rings of the D- and L-enantiomers
overlay quite well. This permits the preservation,
regardless of the chirality of dA, of similar hydrogen
bonding interactions to active site residues (Fig. 5a).
By tilting the base of L-dA compared to that of D-dA,
the enzyme is able to position the 3′- and 5′-OH
groups of L-dA in the same positions as those
adopted by D-dA (Fig. 5b). Such relative base tilting
was also observed between the D-dC and L-dC
complexes.5 This tilting is significant, as it allows the
5′-OH group to maintain its hydrogen bonding
distance to Glu53 (Fig. 5a).
Comparison of the D-dA/UDP to L-dA/UDP
structure
The results presented earlier showed that in the
case of the nucleoside D-dA the conformation ofdCK is dependent on the nature of the nucleotide at
the donor site (ADP versus UDP). This raised the
question of whether this phenomenon would also
occur with the L-form of the nucleoside, or is it
specific for D-dA. To address this, we solved the
structure of dCK in complex with L-dA and UDP.
Comparison of the L-dA/UDP and the D-dA/UDP
complex structures reveals a nearly identical
enzyme conformation (rmsd 0.45 Å on 213 atoms).
In both complexes the enzyme adopts the open/
inactive conformation, as defined by the Glu53
distance from the 5′-OH group. This shows that the
differential conformation of dCK in response to the
nature of the nucleotide at the donor site (e.g. ADP
versus UDP) is not limited to D-dA, and may be a
general property of the enzyme.
However, in contrast to the same protein con-
formation, the nucleosides, L- versus D-dA, bind
differently depending on their chirality. With UDP
in the donor site, D-dA binds in synwhile L-dA binds
in anti. Despite their different conformation, the
adenine bases of the two enantiomers overlap
almost perfectly and maintain the same hydrogen
bonding pattern with Asp133 and Gln97 (Fig. 5c).
This is observed also for the same enantiomeric
couple in complex with ADP (Fig. 5a). However,
since L-dA binds in anti, the deoxyribose sugar is
positioned in a mirror fashion to the sugar of D-dA
(Fig. 5c). Interestingly, this still allows the 3′-OH
group of L-dA to occupy a comparable position to
Fig. 5. Regardless of the chirality of the nucleoside, dCK adopts an active conformation if ADP is present at the donor
site, and an inactive conformation if UDP is present at the donor site. (a) An overlay of the D-dA/ADP (dark blue) and
L-dA/ADP (dark pink) structures shows a very similar enzyme (closed) and nucleoside (anti) conformation. (b) A ∼90°
rotation relative to the view in panel a. The binding of the L-enantiomer is characterized by a base tilt of∼10° relative to its
position in the D-enantiomer (see the schematic at the right). (c) An overlay of the D-dA/UDP (light blue) and L-dA/UDP
(light pink) structures shows a very similar enzyme conformation (open). In both cases the enzyme cannot make the
necessary interactions via Glu53 to the 5′-OH group of the nucleoside. In the D-dA complex the orientation of the sugar is
correct, but the distance is too large (4.4 Å). In the L-dA complex, the nucleoside is in the anti conformation, but the sugar is
pointing in the opposite direction (towards Met85) to what would allow Glu53 to activate it. Thus, in both complexes of
UDP with L-dA or D-dA, the enzyme conformation represents an inactive state. (d) A ∼90° rotation relative to the view in
(a). In the structures with UDP, both bases adopt the same tilt (see the schematic at the right). Note how Trp58 in the UDP
family of structures turns by 45° away from the adenine base of dA compared to the ADP family of structures (see (b) use
Phe96 as a reference) and how Tyr86 and Glu197 move down (this movement is visible also in Fig. 3).
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towards Met85 instead of Glu53, as was seen for
D-dA. This corresponds to an inactive conformation,
albeit different from that seen in the D-dA/UDP
complex. In the latter, while the 5′-OH group is too
far from Glu53 for this side chain to activate the
hydroxyl group for attack on the phosphoryl donor
(4.4 Å), the 5′-OH still faces Glu53 (Fig. 5c).
As was argued for the case of D-dA and UTP as
donor, we interpret this inactive enzyme conforma-tion to represent an intermediate state, and that such
a state can easily transition to an active state. In fact,
kinetic analysis shows that L-dA has similar kcat and
Km values to D-dA when using UTP as phosphoryl
donor (Table 2). This suggests that for both cases the
enzyme can efficiently transition from the inactive
states we observe to a state that is catalytically
competent. At the same time, the kinetics for both of
the nucleosides D-dA and L-dA show a higher kcat
with ATP, consistent with the fact that with this
Fig. 6. Tryptophan fluorescence emission scan reveals
a change in tryptophan signal upon addition of UTP but
no change with ATP. Spectra were recorded for the protein
alone (black), protein with ATP (magenta), and protein
with UTP (yellow). The presence of UTP results in ∼8%
increased tryptophan signal.
617Human dCK in Complex With L/D-d/A and UDP/ADPphosphoryl donor the enzyme avoids the inactive
conformation we see with UDP. In contrast to a
higher kcat with ATP, the Km values for the nucleo-
sides is lower with UTP.
As mentioned above, in the complexes with ADP
the base of L-dA tilts relative to the position of the
base of D-dA to allow productive binding of the non-
physiological enantiomer of dA (Fig. 5b). In contrast,
in the complexes with UDP, no tilting occurs
between the enantiomeric couple of dA (Fig. 5d).
Fluorescence experiments are consistent with
phosphoryl donor-dependent enzyme states
The above structural results revealed a closed
dCK conformation in the presence of ADP, and an
open state in the presence of UDP. To verify that
this phenomenon is not an artifact of the crystalline
state or a unique feature of the C4S-dCK mutant
used for the structural studies, and to test if the
differential states observed with the nucleotide
diphosphates are relevant to the true triphosphate
substrates, we used intrinsic tryptophan fluores-
cence to detect nucleotide-dependent conforma-
tional changes in dCK.
The tryptophan emission intensity of C4S-dCK
does not change significantly upon addition of ATP.
On the other hand, addition of UTP results in a ∼8%
increase in the tryptophan fluorescence signal (Fig.
6). Our structural studies revealed that Trp58
changes its conformation dramatically between the
complexes solved in the presence of ADP to those
solved in the presence of UDP. Thus, the change in
tryptophan fluorescence upon addition of UTP can
be rationalized by the conformational change in
Trp58 as seen in our structures. On the other hand,
the lack of change in tryptophan fluorescence upon
addition of ATP suggests that the apo form of dCK
and the ATP-bound form have a very similar
conformation. The fact that similar changes in
tryptophan signal are observed when the dipho-
sphates (Supplementary Data Fig. S2) are titrated
instead of the triphosphates (Fig. 6) suggest that the
structural data, obtained as the dead-end complexes
with a nucleoside at the acceptor site (D- or L-dA)
and a diphosphate at the donor site (ADP or UDP),
do indeed describe the conformational changes that
occur in dCK upon the productive binding of
substrates. As a further control, to assess the
relevance of the results obtained with the C4S-
variant of dCK to that of the wild type enzyme, we
tested the behavior of WT-dCK in its response to
ADP or UDP binding. Our results show an identical
change in fluorescence of WT-dCK to that of the C4S-
variant (Supplementary Data Fig. S3). Consistent
with both our structural and our tryptophan
fluorescence data are results from the Eriksson
group that also detected, by fluorescence, a change
in dCK conformation due to substrate binding.10,11
In earlier work, pre-steady state experiments sug-
gested that ATP and UTP bind differently to the
enzyme.10 In more recent work, using dCK labeled
with fluorescent probes at various cysteine residues,the researchers determined that the sensitive
cysteine residue in dCK was Cys185.11 This conclu-
sion is consistent with our structural results that
demonstrate a movement in region B, which
includes this residue. In addition, it was concluded
that the loss in energy transfer in these experiments
was due to movement in Trp58. Our results
demonstrate a rare case in which a change in
tryptophan fluorescence seen upon ligand binding
can be correlated directly with a structural change of
a specific tryptophan residue.
The open/catalytically incompetent state is an
intermediate within the dCK catalytic cycle
What supports our interpretation of the open/
inactive state as a true intermediate state that
occurs along the reaction trajectory, versus the
alternative, which is that this state is an off-
pathway dead-end complex? First, previous struc-
tures of dCK in complex with a nucleoside
substrate and a nucleotide product showed a
conformation that is compatible with catalysis.3–5,7
Hence, the mere combination of substrate and
product does not necessarily build an inactive
state, as we observe with dA and UDP. Second,
and more important, is the fact that fluorescence
experiments indicate a change in enzyme conforma-
tion upon UTP (or UDP) binding, but not with ATP
(or ADP). This shows that a UTP-dependent state is
adopted by dCK upon binding of this nucleotide.
Thus, a different dCK conformation, dependent on
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part of the dCK reaction trajectory. Thirdly, kinetic
data have demonstrated a different kinetic behavior
for this enzyme when UTP is used as a donor
instead of ATP (Supplementary Data Fig. S5).12
Thus, the UDP-specific state we observe is consis-
tent with a UDP-specific mechanism. We propose
that the state we observe with UDP describes an
inactive ternary complex formed after the sequen-
tial binding of both substrates (Supplementary Data
Fig. S5). This inactive state must convert to the
closed ternary state to allow phosphoryl transfer to
occur. Due to the specific nature of dA, we were
able to trap this inactive state. With other nucleo-
sides, e.g. dC, this open state also forms, but as the
closed state is more favored, it is the one we observe
in those structures. We have no indication that ATP
can also induce this open enzyme state. Neither in
our structural studies with ADP nor in our
fluorescence experiments with ATP or ADP could
we detect this open conformation.
Determinants of nucleoside binding
The change in dCK conformation between the
open and closed states is limited to the regions that
we defined as regions A, B, and C. The important
residues that show the most profound change are
Trp58 (the source of our tryptophan signal), Asn80
(a residue that allows for region B – region C
communication), and Tyr86 (Fig. 7).
Tyrosine 86 seems to be a crucial residue for the
positioning of the nucleoside. Regardless of the
chirality of dA and of the nature of the nucleotideFig. 7. The overlay of the four complexes highlighting the n
donor, dCK adopts either a closed (with ADP) or an open (with
In all cases, the adenine base occupies the same area, albe
interaction with the 3′-OH group of the nucleosides, but only in
this residue and the base moiety of the nucleoside. (b) Trp58 ch
closed states.at the donor site, this residue maintains in all four
structures presented here an interaction with the
3′-OH group of dA. This is achieved despite the
diversity in positioning of the sugar ring of the
nucleoside seen in our four structures (Fig. 7a).
However, only when the base of the nucleoside
interacts with Tyr86 via a water molecule does the
enzyme adopt the closed (and active) state. An
additional notable point is the equivalent location
of the adenine base in all cases, despite a different
enzyme conformation. Thus, we conclude that two
factors dominate nucleoside binding: One is hav-
ing the base moiety occupy the same binding site,
albeit with freedom of orientation (e.g., the base
can rotate 180°). Two is preserving the 3′-OH
interaction with the Tyr86 hydroxyl group. But
only in the closed state is Tyr86 positioned
correctly to interact with the nucleoside via a
water molecule. Additionally, only in the closed
state is Glu53 able to approach the 5′-OH group
and activate it to attack the γ-phosphate group of
the donor nucleotide.Conclusion
In addition to exposing the binding mode of D-dA,
a physiological purine substrate of dCK, our work
addresses the difference in binding of L- and D-dA,
and the structural ramifications of employing UTP
instead of ATP as phosphoryl donor. One important
conclusion that arises from this work is that dCK can
adopt an open conformation with UTP, and that this
conformation is catalytically incompetent.ucleoside-binding site. (a) Depending on the nature of the
UDP) conformation. This affects binding of the nucleoside.
it with 180° opposite conformation. Tyr86 maintains an
the closed state can a water molecule (green arrow) bridge
anges its conformation dramatically between the open and
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D-dA conformations: syn with UDP, and anti with
ADP. Solution studies reveal that purines undergo
rapid inter-conversion between their syn and anti
conformations.13 One could have surmised that the
requirement for optimal binding to the enzyme
would select only one of the two conformations.
Surprisingly, human dCK can bind both the syn and
anti conformations. This is, to our knowledge, the
first report of an enzyme that can bind to both
conformers (syn and anti) of a nucleoside. This is
made possible by the fact that in both bindingmodes
very similar nucleoside–enzyme interactions occur.
Our work reveals that dCK displays substrate
promiscuity at both the nucleoside acceptor and
nucleotide donor sites. Communication between the
two binding sites results in differential states
according to the nature of substrates. Large varia-
bility in binding mode is possible at the nucleoside
acceptor site. While the base moiety always occupies
the same space, two bindingmodes related by a 180°
rotation are possible. The sugar of the nucleoside is
much less restricted in its conformation. The
conformations observed with UDP represent an
inactive state based on a large 5′-OH – Glu53
distance. Our work reveals the conformational
flexibility of this physiologically important nucleo-
side kinase and shows how purine substrates of
either chirality are accepted as substrates.Material and Methods
Site-directed mutagenesis, protein expression,
purification, and crystallization
The C4S-dCK mutant (C9S/C45S/C59S/C146S) was
engineered, over-expressed and purified as described.4,5
Briefly, we made the mutant using the QuickChange Site-
Directed Mutagenesis Kit from Stratagene using as
template the WT-dCK gene cloned into the pET14b vector.
The BL21(DE3) Escherichia coli strain carrying the recom-
binant plasmid coding for His-tagged C4S-dCK was
grown in 2YT medium at 37 °C, induced with 0.1 mM
IPTG and harvested after 4 h. After sonication of the cell
pellet, the lysate was loaded onto a HisTrap HP column
packed with 5 ml of Ni Sepharose high-performance resin
(Amersham Biosciences). After loading, the column was
washed with 500 ml of buffer containing 20 mM imidazole
(pH 7.5), and protein was eluted with 200 mM imidazole
(in 50 mM Hepes (pH 7.5) and 500 mM NaCl). EDTA
(2 mM) was added immediately to the eluted protein to
avoid degradation by traces of proteases. The His-tag was
not cleaved, and the protein was further purified on an S-
200 gel-filtration chromatography column (Amersham
Biosciences) using as gel-filtration buffer 20 mM Hepes
(pH 7.5), 200 mM sodium citrate, 2 mM EDTA. The C4S
mutant was then crystallized in complex with ADP or
UDP and the enantiomeric couple D-dA and L-dA using
the vapor-diffusion method in the hanging-drop geome-
try. D-dAwas obtained from Sigma, while L-dAwas from
ChemGenes Corporation. The complexes were formed by
mixing 5 mM nucleoside (D- or L-dA) with 5 mM
nucleotide (ADP or UDP) and the enzyme (15–20 mg/
ml in gel-filtration buffer plus 5 mM MgCl2). Crystal-lization trials were also carried out with the nucleotide
analogs UppNHp (Jena Biosciences) and AppNHp
(Sigma). While crystals were produced, none was of
sufficient quality for structural studies.
For the D-dA/ADP complex, the use of the C4S-dCK
mutant proved to be unsuccessful in providing crystals.
For a different purpose, we designed a variant of dCK that
included the C4S mutation plus the additional mutation of
Glu247 to alanine. With this mutant we could produce X-
ray diffraction quality crystals for the D-dA/ADP com-
plex. All the crystals for the D-/L-dA plus ADP/UDP
complexes were obtained from hanging drops (1 μl of
protein/nucleoside/nucleotide/MgCl2 mix plus 1 μl of
reservoir) using a reservoir solution that contained 0.90–
1.5 M trisodium citrate dihydrate and 100 mM Hepes, pH
7.5. Formation of X-ray quality diffraction crystals for the
four complexes was highly dependent on the temperature
at which the drops were incubated. The ADP complexes
yielded crystals at room temperature while the UDP
complexes crystallized only at 12 °C. Interestingly, by
changing the temperature and complex type, dCK
produced beautiful crystals characterized by different
shapes: the ADP crystals exhibited the typical shape of all
our previous crystals for which we determined the
structure in space group C2221 or P43212, while the UDP
crystals were shaped like rice grains.
Crystallographic data collection and processing
Crystals were transferred to a cryoprotectant solution,
consisting of mineral oil (Sigma), mounted in loops, and
frozen by immersing them directly in liquid nitrogen. X-
ray data for the D-dA/ADP crystal were collected at the
Advanced Photon Source, Argonne National Laboratories
using the SERCAT beamline ID-22, while those for L-dA/
ADP, D-dA/UDP and L-dA/UDP were collected in-house
using RAXIS-IVas detector. The data were indexed, scaled
and merged using XDS and XSCALE (see Table 1 for data
collection statistics).14
Structure determination and refinement
For the two ADP-containing complexes we could
commence directly by applying rigid body refinement.
For the D-dA/ADP structure our initial model was PDB
Code 1P60 while for the L-dA/ADP structure crystallized
in space group P43212 it was PDB Code 1P5Z. For the two
complexes with UDP it was necessary to perform
molecular replacement, done with Molrep15 with 1P5Z
as the search model. In order to prepare a good starting
model and avoid any possible bias during refinement,
residues 55–82 were deleted from each monomer of
structure 1P60 (which is a dimer) and from structure
1P5Z (a monomer). This area follows the nucleophilic base
Glu53 and includes the insert region. Moreover, for the
starting model of the UDP structures, residues 238–254
were also deleted because our previous work revealed
that this region is sensitive to the identity of the
diphosphate.7 Restrained refinement for the D-dA/ADP
and L-dA/ADP structures was carried out using
REFMAC16 (for the L-dA/ADP complex, data scaled
well to 1.76 Å, but refinement was best to 2.2 Å). Since
both UDP structures showed perfect twinning (see Table 1
for twinning fraction of data sets), refinement for these
two structures was done using SHELXL by use of
conjugate-gradient least-squares refinement.17 The elec-
tron density map (2Fobs–Fcalc and omit) for the nucleosides
D-dA and L-dA in the ADP and UDP complexes is shown
620 Human dCK in Complex With L/D-d/A and UDP/ADPin (Supplementary Data Fig. S4). Arg128, an active site
residue, is in the disallowed region of the Ramachandran
plot. This is a common feature for this enzyme.
Steady-state kinetic assay
A spectroscopic enzyme-coupled assay was used to
determine the activity of both WT, C4S and C4S+E247A
dCK as described18 in 50 mM Tris–HCl (pH 7.5), 100 mM
KCl, and 5 mM MgCl2 at 37 °C with 0.35 μM dCK, 1 mM
ATP-Mg and 1 mM UTP-Mg. D-dA and L-dA concentra-
tions were varied between 50 μM and 600 μM when ATP
was used as phosphate donor and 5 μM to 100 μM with
UTP (Table 2).
Fluorescence
Intrinsic tryptophan fluorescence measurements of
proteins were recorded using a Quanta Master spectro-
fluorimeter (Photon Technology International, London,
Ontario, Canada). The excitation wavelength was 295 nm,
to ensure excitation of only the tryptophan, with slits of
1 nm for excitation and 4 nm for emission. Emission was
recorded between 310 nm and 350 nm in steps of 1 nm
with an integration time of 1 s at 25 °C.
All solutions were prepared in 0.05 M sodium phos-
phate buffer, pH 7.5. The temperature of the samples was
maintained at 25 °C using a thermostatically controlled
cell holder. Fluorescence spectra were taken in a two-step
process, first the spectrum of the protein (30 μM) was
taken, and then UTP or ATP was added, and an additional
spectrum taken. No significant change in signal was
observed upon addition of dA, either to the apo or the
UDP-complexed dCK.
Protein Data Bank accession codes
Structures have been deposited in the PDB with
accession codes 2ZI3 for the D-dA/ADP, 2ZI4 for the L-
dA/ADP, 2ZI6 for the D-dA/UDP, and 2ZI5 for the L-dA/
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